MRD Clinical Account Executive, North LA
Tempus AI
Summary
Candidate must reside in the North Los Angeles Territory.
Job description
The MRD Clinical Account Executive is responsible for promoting and selling Tempus's Minimal Residual Disease (MRD) testing services to clinicians and healthcare providers. The role involves strategic business development, collaboration with key stakeholders, and driving the adoption of MRD testing within academic medical centers, health systems, and community practices.
Responsibilities
- Drive the adoption of Tempus's MRD testing services within the specified territory, focusing on major U.S. cancer centers, health systems, and community practices.
- Engage with Key Opinion Leaders (KOLs), clinicians, and decision-makers to establish and expand business opportunities.
- Develop strategic plans for acquiring new clients and retaining existing ones, maximizing client-bill contracting opportunities.
- Implement laboratory services agreements (LSAs) with institutions that opt for client billing.
- Collaborate with various sales roles within Tempus to ensure the attainment of company goals and objectives.
- Identify and develop partnership opportunities between oncology clients and Tempus, promoting the integration of MRD testing into clinical practice.
- Provide feedback to Tempus leadership based on market analysis and competitive landscape within assigned accounts.
- Develop and implement a comprehensive business plan for the territory, including budgets, travel, territory management, and goal setting.
- Represent Tempus's company culture with integrity, respect, and trust to both external and internal stakeholders.
Requirements
- Proven ability to sell integrated molecular diagnostic solutions and engage in consultative selling processes.
- Comfortable engaging with executive-level stakeholders (CEO, COO, CFO).
- In-depth understanding of the payer and reimbursement environment in oncology diagnostics.
- Independent work ethic with strong communication, project management, and prioritization skills.
- Knowledgeable about molecular diagnostics, MRD testing, and the competitive landscape in oncology.
- Proficient in Microsoft Office products, particularly Excel and PowerPoint, and regular use of Salesforce.com.
- Ability to develop cross-functional relationships to facilitate work goals and objectives.
- Advanced presentation skills, business acumen, and the ability to work effectively with minimal direction.
Qualifications
- B.S. in life science, biology, business, or marketing – MBA preferred.
- 3+ years of direct account management experience in a molecular diagnostic setting, with a focus on MRD testing preferred.
- Proven track record of revenue generation in a diagnostic, pharmaceutical, or biotechnology company.
- Experience working with major cancer centers, oncology GPOs, large health systems, and oncology practices.
Requirements
- Proven ability to sell integrated molecular diagnostic solutions and engage in consultative selling processes.
- Comfortable engaging with executive-level stakeholders (CEO, COO, CFO).
- In-depth understanding of the payer and reimbursement environment in oncology diagnostics.
- Independent work ethic with strong communication, project management, and prioritization skills.
- Knowledgeable about molecular diagnostics, MRD testing, and the competitive landscape in oncology.
- Proficient in Microsoft Office products, particularly Excel and PowerPoint, and regular use of Salesforce.com.
- Ability to develop cross-functional relationships to facilitate work goals and objectives.
- Advanced presentation skills, business acumen, and the ability to work effectively with minimal direction.
- B.S. in life science, biology, business, or marketing – MBA preferred.
- 3+ years of direct account management experience in a molecular diagnostic setting, with a focus on MRD testing preferred.
- Proven track record of revenue generation in a diagnostic, pharmaceutical, or biotechnology company.
- Experience working with major cancer centers, oncology GPOs, large health systems, and oncology practices.
Benefits
- Incentive compensation
- Restricted stock units
- Medical benefits
Company overview
Tempus AI, Inc. (NASDAQ: TEM) is a pioneering healthcare technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. The company was established after Lefkofsky's wife was diagnosed with breast cancer, driving his mission to revolutionize cancer care through technology and artificial intelligence. Tempus specializes in applying AI to advance precision medicine by collecting and analyzing vast amounts of molecular, clinical, and genomic data. The company operates across multiple therapeutic areas including oncology, cardiology, radiology, neurology, psychiatry, and dermatology. Tempus provides comprehensive diagnostic services including next-generation sequencing (NGS), PCR profiling, and molecular pathology testing. Its AI-powered platform enables physicians to make real-time, data-driven decisions for personalized patient care and targeted therapies. The company went public in June 2024 and has expanded globally with operations in multiple countries. Tempus continues to innovate at the intersection of healthcare and artificial intelligence, aiming to ensure patients receive the right treatments at the right time for improved health outcomes.